Design Therapeutics Competitors and Similar CompaniesClear all

Design Therapeutics's competitors and similar companies include Y-mAbs Therapeutics and Prevail Therapeutics.
Design Therapeutics
Design Therapeutics
Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates.
Y-mAbs Therapeutics
Y-mAbs Therapeutics
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
Prevail Therapeutics
Prevail Therapeutics
Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
Founding Date
Founding Date
2017
Founding Date
2014
Founding Date
2017
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Carlsbad, US HQ
Locations
New York, US HQ
Copenhagen, DK
Nutley, US
Locations
New York, US HQ
Employees
Employees
54
Employees
3239% increase
Employees
489% increase
Valuation ($)
Valuation ($)
313.1 m
Valuation ($)
657 m
Valuation ($)
787.7 m

Financial

Net income
Net income
($69.8m) (FY, 2025)
Net income
($29.7m) (FY, 2024)
Net income
($63.2m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 45m
Total funding raised
$ 80m
Total funding raised
$ 125m
For sources of this data, please see the company profile

View Company Profiles

Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase

Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.

View company
Prevail Therapeutics
HQ
New York, US
Employees
48↑ 9% increase

Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.

View company